trending Market Intelligence /marketintelligence/en/news-insights/trending/apm4hxboiiqwleg0imtjgg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

BioTime director to step down

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


BioTime director to step down

BioTime Inc. said David Schlachet will step down from the company's board of directors and will not seek reelection at the company's 2018 annual meeting.

Schlachet's decision to step down was due to the logistics of being a director of the company while living in Israel. He will remain a director of Cell Cure Neurosciences Ltd., an Israel-based unit of BioTime.

The Alameda, Calif.-based company develops therapies for degenerative diseases.